Andersons pediatric cardiology 383
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.78 KB, 3 trang )
2007;55(3):156–162.
95.BeierleinW,BeckerV,YatesR,etal.Long-term
follow-upaftermitralvalvereplacementin
childhood:poorevent-freesurvivalintheyoung
child.EurJCardiothoracSurg.2007;31(5):860–
865.
96.SawanEB,BrinkJ,SoquetJ,etal.Theordealof
leftatrioventricularvalvereplacementin
childrenunder1yearofage.Interact
CardiovascThoracSurg.2017;25(2):317–322.
97.LaplaceG,LafitteS,LabequeJN,etal.Clinical
significanceofearlythrombosisafterprosthetic
mitralvalvereplacement:apostoperative
monocentricstudyof680patients.JAmColl
Cardiol.2004;43(7):1283–1290.
98.RaghuveerG,CaldaroneCA,HillsCB,etal.
Predictorsofprosthesissurvival,growth,and
functionalstatusfollowingmechanicalmitral
valvereplacementinchildrenaged<5years,a
multi-institutionalstudy.Circulation.
2003;108(suppl1):II174–II179.
99.BryanAJ,RogersCA,BaylissK,WildJ,
AngeliniGD.Prospectiverandomized
comparisonofCarboMedicsandSt.Jude
Medicalbileafletmechanicalheartvalve
prostheses:ten-yearfollow-up.JThorac
CardiovascSurg.2007;133(3):614–622.
100.JamiesonWR,MiyagishimaRT,Grunkemeier
GL,etal.Bileafletmechanicalprostheses
performanceinmitralposition.EurJ
CardiothoracSurg.1999;15(6):786–794.
101.PuskasJ,GerdischM,NicholsD,etal.Reduced
anticoagulationaftermechanicalaorticvalve
replacement:interimresultsfromthe
prospectiverandomizedon-Xvalve
anticoagulationclinicaltrialrandomizedFood
andDrugAdministrationinvestigationaldevice
exemptiontrial.JThoracCardiovascSurg.
2014;147(4):1202–1210[discussion1210–
1211].
102.AmanK.Mechanicalaorticvalvewithout
anticoagulationfor33yearsinaYemeniman:a
casereport.JMedCaseRep.2016;10(1):189.
103.KonnoS,ImaiY,IidaY,NakajimaM,Tatsuno
K.Anewmethodforprostheticvalve
replacementincongenitalaorticstenosis
associatedwithhypoplasiaoftheaorticvalve
ring.JThoracCardiovascSurg.
1975;70(5):909–917.
104.NicksR,CartmillT,BernsteinL.Hypoplasiaof
theaorticroot.Theproblemofaorticvalve
replacement.Thorax.1970;25(3):339–346.
105.RastanD.Aorticandaortic-mitralannular
enlargement.JThoracCardiovascSurg.
1995;109(4):818–819.
106.ManouguianS.Anewmethodforpatch
enlargementofhypoplasticaorticannulus.An
experimentalstudy(author'stransl).Thoraxchir
VaskChir.1976;24(5):418–423.
107.BurdonTA,MillerDC,OyerPE,etal.
Durabilityofporcinevalvesatfifteenyearsina
representativeNorthAmericanpatient
population.JThoracCardiovascSurg.
1992;103(2):238–251[discussion251–252].
108.CohnLH,CollinsJJJr,DiSesaVJ,etal.Fifteenyearexperiencewith1678Hancockporcine
bioprostheticheartvalvereplacements.Ann
Surg.1989;210(4):435–442[discussion442–
443].
109.JonasRA.ComprehensiveSurgicalManagement
ofCongenitalHeartDisease.2nded.CRC
Press,TaylorandFrancisGroup:BocaRaton,
Florida;2014:395–420[ValveRepairand
Replacement].
110.TurrentineMW,RuzmetovM,VijayP,BillsRG,
BrownJW.Biologicalversusmechanicalaortic
valvereplacementinchildren.AnnThoracSurg.
2001;71(5suppl):S356–S360.
111.SchoenFJ,LevyRJ.Calcificationoftissueheart
valvesubstitutes:progresstowardunderstanding
andprevention.AnnThoracSurg.
